Optimization of

CD4+ TEM cells Kv1.3 blocker Pichia pastoris margatoxin patch-clamp recombinant expression

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 30 06 2021
accepted: 30 08 2021
entrez: 18 10 2021
pubmed: 19 10 2021
medline: 19 10 2021
Statut: epublish

Résumé

Margatoxin (MgTx) is a high-affinity blocker of voltage-gated potassium (Kv) channels. It inhibits Kv1.1-Kv1.3 ion channels in picomolar concentrations. This toxin is widely used to study physiological function of Kv ion channels in various cell types, including immune cells. Isolation of native MgTx in large quantities from scorpion venom is not affordable. Chemical synthesis and recombinant production in

Identifiants

pubmed: 34658872
doi: 10.3389/fphar.2021.733610
pii: 733610
pmc: PMC8511391
doi:

Types de publication

Journal Article

Langues

eng

Pagination

733610

Informations de copyright

Copyright © 2021 Naseem, Tajti, Gaspar, Szanto, Borrego and Panyi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biotechnol Lett. 2005 Mar;27(5):339-45
pubmed: 15834796
Rev Physiol Biochem Pharmacol. 2000;140:135-85
pubmed: 10857399
Curr Pharm Des. 2006;12(18):2199-220
pubmed: 16787250
Yeast. 2005 Mar;22(4):249-70
pubmed: 15704221
Toxicon. 2012 Sep 15;60(4):492-501
pubmed: 22497787
Toxicon. 2009 Jul;54(1):56-61
pubmed: 19306891
Methods Mol Biol. 2007;389:1-10
pubmed: 17951631
Protein Sci. 2003 Jul;12(7):1332-43
pubmed: 12824480
Mol Pharmacol. 2005 Apr;67(4):1034-44
pubmed: 15615696
J Clin Invest. 2003 Jun;111(11):1703-13
pubmed: 12782673
Appl Biochem Biotechnol. 2010 Mar;160(5):1321-31
pubmed: 19412581
BMC Biotechnol. 2011 May 10;11:47
pubmed: 21569231
FEMS Yeast Res. 2008 Sep;8(6):870-6
pubmed: 18637138
FASEB J. 1996 Jan;10(1):49-56
pubmed: 8566547
Cell Rep. 2016 Sep 6;16(10):2749-2762
pubmed: 27568555
J Biol Chem. 2014 May 2;289(18):12623-32
pubmed: 24644290
Immunol Rev. 2009 Sep;231(1):59-87
pubmed: 19754890
Front Neurosci. 2020 Jan 14;13:1393
pubmed: 31992966
Sci Rep. 2014 Mar 28;4:4509
pubmed: 24676092
J Biol Chem. 1998 Dec 4;273(49):32697-707
pubmed: 9830012
Microb Cell Fact. 2012 May 08;11:56
pubmed: 22569138
Toxicon. 2014 Sep;87:6-16
pubmed: 24878374
Front Pharmacol. 2021 Jan 19;11:586599
pubmed: 33841132
Channels (Austin). 2021 Dec;15(1):53-66
pubmed: 33356811
Sci Rep. 2015 Dec 22;5:18397
pubmed: 26689143
J Membr Biol. 2001 Jan 1;179(1):13-25
pubmed: 11155206
Toxicon. 2004 Jun 15;43(8):877-86
pubmed: 15208020
J Exp Med. 1998 Oct 5;188(7):1369-73
pubmed: 9763616
Trends Cardiovasc Med. 2016 Apr;26(3):209-18
pubmed: 26391345
Biomed Res Int. 2015;2015:248680
pubmed: 26171389
J Biol Chem. 1996 Feb 16;271(7):3763-70
pubmed: 8631992
Structure. 1994 Nov 15;2(11):1003-5
pubmed: 7881900
J Physiol Sci. 2015 Jan;65(1):25-35
pubmed: 25096892
Toxicon. 2012 Mar 15;59(4):529-46
pubmed: 21867724
Appl Microbiol Biotechnol. 2006 Sep;72(3):492-8
pubmed: 16532314
Appl Microbiol Biotechnol. 2007 Apr;74(5):1074-83
pubmed: 17216453
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130106
pubmed: 24493754
PLoS One. 2013 May 07;8(5):e63865
pubmed: 23667680
FEBS J. 2015 Jun;282(12):2247-59
pubmed: 25864722
Biochemistry. 1993 Jul 13;32(27):6982-7
pubmed: 7687466
PLoS One. 2017 Jul 19;12(7):e0180762
pubmed: 28723914
J Biotechnol. 2001 Jun 1;88(1):21-35
pubmed: 11377762
PLoS One. 2012;7(12):e52965
pubmed: 23300835
Toxicon. 2011 Feb;57(2):348-55
pubmed: 21194541
Ann N Y Acad Sci. 1999 Apr 30;868:233-85
pubmed: 10414301
Acta Pharm. 2016 Mar;66(1):23-34
pubmed: 27029082
J Neurochem. 2021 Jun;157(6):1876-1896
pubmed: 32978815
Drug Dev Res. 2011 Nov;72(7):573-584
pubmed: 22241939
Mol Pharmacol. 2012 Sep;82(3):372-82
pubmed: 22622363
Cell Commun Signal. 2018 Aug 14;16(1):45
pubmed: 30107837
Mar Drugs. 2015 Jan 16;13(1):529-42
pubmed: 25603346
Inflamm Allergy Drug Targets. 2011 Oct;10(5):313-21
pubmed: 21824083
Infect Immun. 2003 Sep;71(9):4961-9
pubmed: 12933838
Expert Opin Biol Ther. 2017 Sep;17(9):1065-1075
pubmed: 28695745
Trends Pharmacol Sci. 2004 May;25(5):280-9
pubmed: 15120495
Protein Sci. 2006 May;15(5):1115-26
pubmed: 16597836
Biochem Pharmacol. 2020 Nov;181:114146
pubmed: 32653588
Protein Expr Purif. 2008 Jun;59(2):282-8
pubmed: 18378165
J Biosci Bioeng. 2000;89(5):479-84
pubmed: 16232781
Sci Rep. 2013 Oct 24;3:3043
pubmed: 24154717
Immunobiology. 2013 Mar;218(3):311-6
pubmed: 22705192
Pathobiology. 2020;87(5):311-316
pubmed: 32911471
Protein Expr Purif. 2011 Dec;80(2):283-93
pubmed: 21871965
J Vasc Res. 2005 Sep-Oct;42(5):368-76
pubmed: 16043967
J Biol Chem. 1993 Sep 5;268(25):18866-74
pubmed: 8360176
Trends Pharmacol Sci. 2003 May;24(5):222-7
pubmed: 12767720
Biotechnology (N Y). 1991 May;9(5):455-60
pubmed: 1367310
Biochemistry. 1994 Dec 20;33(50):15061-70
pubmed: 7999764

Auteurs

Muhammad Umair Naseem (MU)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Gabor Tajti (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Attila Gaspar (A)

Department of Inorganic and Analytical Chemistry, Faculty of Science and Technology, Institute of Chemistry, University of Debrecen, Debrecen, Hungary.

Tibor G Szanto (TG)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Jesús Borrego (J)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Gyorgy Panyi (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Classifications MeSH